VN April 2026

Vetnuus | April 2026 17 Article When comparing across regions, no statistically significant differences in the seroprevalence of B. burgdorferi s. l. were detected (P=0.180), although the rates varied from 11% (CI: 2-29) in Northern Norway, to 18% (CI: 13-24) in Eastern Norway, 19% (CI: 5-42) in Central Norway, 20% (CI 12-30) in Western Norway, and 25% (CI: 16-35) in Southern Norway (Figure 2). In contrast, statistically significant regional differences in seroprevalence were observed for TBEV (P=0.043). The highest seroprevalence was found in Southern Norway (28%, CI: 1938), followed by Central (24%, CI: 8-47) and Eastern Norway (20%, CI: 14-26), whereas the lowest was seen in Northern (11%, CI: 2-29) and Western Norway (11%, CI: 5-19). Similarly, a highly significant regional difference was detected for A. phagocytophilum (P=0.0001), with the highest seroprevalence observed in Western (23%, CI: 1430), Southern (22%, Cl: 14-31), and Central Norway (14%, CI: 3-36), compared to a markedly lower seroprevalence in Eastern Norway (2%, CI: 1-6) and no positive samples detected in Northern Norway (0%, CI: 0-13). These statistically significant regional differences for TBEV and A. phagocytophilum persisted after adjusting for age, sex, and breed, indicating robust geographical variation in exposure. Seroprevalence by age, sex, and breed is presented in Table 2. A significant difference was observed between age groups when analysing for IgG antibodies against A. phagocytophilum (P=0.003), with the highest seroprevalence detected among senior dogs (17%, 27/164), followed by adults (6%, 10/156), puppies (4%, 1/26), and young dogs (0%, 0/27). In contrast, no significant differences were detected between age groups for antibodies against B. burgdorferi s. l. and TBEV. For the most represented breeds and between sexes, there were no significant differences for any of the tickborne pathogens. However, it should be noted that none of the 17 Border Collie samples tested positive for IgG antibodies against B. burgdorferi s. l. Correlation between canine seroprevalence and human Lyme borreliosis incidence and tick-borne encephalitis Regions with high canine B. burgdorferi s. l. Seroprevalence corresponds to the reported high human Lyme borreliosis incidence (R²=0.739; Table 3). This suggests that approximately 74% of the variation in human incidence could be explained by regional differences in canine seroprevalence. In contrast, no correlation was observed between canine seroprevalence of TBEV and human TBE incidence. All TBE infections reported were restricted to Southern and Eastern Norway. Figure 2: Seroprevalence of IgG antibodies against B. burgdorferi s. l., TBEV, and A. phagocytophilum in dogs residing in regions across Norway. Asterisks (*) denote statistically significant overall variation across regions. Error bars represent 95% confidence intervals. Variable Category Number of dogs (n=433) Bbsl %(n) TBEV % (n) Ap % (n) Age Puppy (0-1 year) 26 23 (6) 12 (3) 4 (1) Young (1-2 years) 27 26 (7) 15 (4) 0 (0) Adult (2-8 years) 156 21 (32) 22 (32) 6 (10) Senior (>8) 164 18 (30) 19 (31) 17 (27) n/a1 60 17 (10) 23 (14) 15 (9) Breed Border Collie 17 0 (0) 24 (4) 6 (1) English Setter 12 17 (2) 33 (4) 8 (1) Golden Retriever 11 18(2) 27 (3) 18 (2) Gordon Setter 10 30 (3) 50 (5) 10 (1) Irish Wolfhound 10 30 (3) 0 (0) 0 (0) Mixed breed 82 23 (19) 23 (19) 11 (9) Other2, n/a1 291 19 (56) 17 (49) 11 (33) Sex Female 184 15 (28) 21 (39) 9 (16) Male 164 20 (33) 17 (28) 11 (18) n/a1 85 26 (22) 19 (16) 13 (11) Table 2 title: Seroprevalence against tick-borne pathogens by age, sex, and breed in the sampled dog population. Table 2 legends: Seroprevalence against Borrelia burgdorferi sensu lato (Bbsl), tick-borne encephalitis virus (TBEV), and Anaplasma phagocytophilum (Ap) by age, sex, and breed in the sampled dog population. 1n/a: not available; 2Other: Breeds with fewer than 10 dogs.

RkJQdWJsaXNoZXIy OTc5MDU=